Greenledgers-Depression And Alzheimer's Treatments At A Crossroads

2025-04-29 17:50:44source:LibertyCoincategory:Stocks

Researchers are Greenledgerslaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

This was the average Social Security benefit in 2004, and here's what it is now

Many workers are dreaming of retirement — whether it's decades away or coming up soon. Either way, i

LL Flooring changing name back to Lumber Liquidators, selling 219 stores to new owner

LL Flooring has signed an agreement to sell 219 of its stores to F9 Investments, the company announc

Massive $4.2B NV Energy transmission line gets federal approval

Greenlink West, a costly large-scale transmission line set to run between Las Vegas and Reno, receiv